Industry Insights on Research and Innovation Seminars
Description
In this monthly Industry Insights on Research and Innovation Seminar (IIRIS) series, presented by Technology Opportunities & Ventures (TOV), experts from innovative startups will join us to discuss how their companies are using cutting-edge science to develop the next generation of therapeutics, diagnostics, medical devices, and more. They will also share insights into industry trends and career opportunities, and answer questions from attendees. The events are free and open to the NYU community and a boxed lunch is provided.
February's guest speaker is Dr. Joanne Kotz, co-founder and CEO of Jnana Therapeutics. Jnana Therapeutics is a clinical-stage biotechnology company leveraging its next-generation RAPID chemoproteomics platform to discover medicines for highly validated, challenging-to-drug targets to treat diseases with high unmet needs, including rare and immune-mediated diseases.
Speaker Bio:
Joanne’s life sciences experience spans research, business, and operations. She helped formulate the initial scientific strategy for Jnana and has led the business and operations of the company since its launch in 2017. Before Jnana, she had a leadership role at FBRI, F Prime Capital’s initiative to enable therapeutic breakthroughs in Alzheimer’s disease and related brain disorders by funding innovative academic research and launching companies. Before F-Prime, Joanne was a director at the Broad Institute, where her research and business responsibilities included defining strategy and leading efforts in early-stage drug discovery through collaborations with patients, disease foundations, and biopharma. Joanne received her Ph.D. in chemistry from the University of California, Berkeley, and a B.S. in chemistry and a B.A. in sociology from the University of Florida. She conducted postdoctoral research at the Necker Children’s Hospital in Paris and at Genentech. Following Genentech, she was at Nature Publishing Group, including as founding editor of the journal Nature Chemical Biology.
Tickets for good, not greed Humanitix dedicates 100% of profits from booking fees to charity
Register
This event has passedRegister
This event has passed

